Abstract:
:Cyclic and acyclic nitroaryl phosphoramide mustard analogues were activated by E. coli nitroreductase, an enzyme explored in GDEPT. The more active acyclic 4-nitrobenzyl phosphoramide mustard (7) showed 167 500x selective cytotoxicity toward nitroreductase-expressing V79 cells with an IC(50) as low as 0.4 nM. This is about 100x more active and 27x more selective than CB1954 (1). The superior activity was attributed to its better substrate activity (k(cat)/K(m) 19x better than 1) and/or excellent cytotoxicity of phosphoramide mustard released.
journal_name
J Med Chemjournal_title
Journal of medicinal chemistryauthors
Hu L,Yu C,Jiang Y,Han J,Li Z,Browne P,Race PR,Knox RJ,Searle PF,Hyde EIdoi
10.1021/jm034133hkeywords:
subject
Has Abstractpub_date
2003-11-06 00:00:00pages
4818-21issue
23eissn
0022-2623issn
1520-4804journal_volume
46pub_type
杂志文章abstract::Kadsurenone, a specific receptor antagonist of platelet-activating factor (PAF), and its analogues were prepared from derivatives of cinnamyl alcohol and (allyloxy)phenol. Racemic kadsurenone, resolvable by a Chiralpak column at low temperatures, has an IC50 value of 2 X 10(-7) M, which is about 50% of the activity of...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00384a023
更新日期:1987-01-01 00:00:00
abstract::5'-(Bromoacetamido)-2',5'-dideoxyuridine (3) and derivatives (8, 10, 12, and 14) substituted at the 5-position with bromo, iodo, fluoro, and ethyl groups have been synthesized as potential inhibitors of enzymes that metabolize pyrimidine nucleosides. Also prepared were 2',5'-dideoxyuridine derivatives (4-6) substitute...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00388a031
更新日期:1987-05-01 00:00:00
abstract::The structure-based design, synthesis, and biological activity of a novel indazole-containing inhibitor series for S-adenosyl homocysteine/methylthioadenosine (SAH/MTA) nucleosidase are described. Use of 5-aminoindazole as the core scaffold provided a structure-guided series of low nanomolar inhibitors with broad-spec...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm0302039
更新日期:2003-12-18 00:00:00
abstract::A novel lysine-based trifunctional chelate 3 was designed, synthesized, and characterized and bears both a chelating moiety (CHX-A' ') for sequestering radiometals (86Y or 111In) and the near-infrared dye Cy5.5 for dual modality PET (or SPECT) and fluorescence imaging, respectively. Successful conjugation of 3 to the ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm070657w
更新日期:2007-09-20 00:00:00
abstract::The cyclopropyl compounds (Z)- and (E)-2-amino-2,3-methano-4-phosphonobutanoic acid, 5 and 6, respectively, were prepared as constrained analogues of 2-amino-4-phosphonobutanoic acid (AP4), a selective glutamate receptor ligand. A Horner-Emmons reaction of trimethyl N-(benzyloxycarbonyl)phosphonoglycinate with 2-(diet...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00109a023
更新日期:1991-05-01 00:00:00
abstract::Accumulation of beta-amyloid aggregates (Abeta) in the brain is linked to the pathogenesis of Alzheimer's disease (AD). We report a novel approach for producing 1,4-diphenyltriazoles as probes for targeting Abeta aggregates in the brain. The imaging probes, a series of substituted tricyclic 1,4-diphenyltriazoles showi...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm070467l
更新日期:2007-07-12 00:00:00
abstract::A series of C7-O- and C20-O-amidated 2,3-dehydrosilybin (DHS) derivatives ((+/-)-1a-f and (+/-)-2), as well as a set of alkenylated DHS analogues ((+/-)-4a-f), were designed and de novo synthesized. A diesteric derivative of DHS ((+/-)-3) and two C23 esterified DHS analogues ((+/-)-5a and (+/-)-5b) were also prepared ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm900735p
更新日期:2009-12-10 00:00:00
abstract::6-Substituted 6-deoxy-L-galactose (L-fucose) derivatives were synthesized as potential antimetabolites of L-fucose. The cytotoxic effects of these compounds were evaluated on P388 leukemia cells in culture. The L-fucose analogues which showed the most potent growth inhibition were the sulfonyl ester, bromo, and iodo d...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00194a017
更新日期:1979-08-01 00:00:00
abstract::A structure-activity analysis of peptides containing backbone C alpha-methyl modification at the P4 site of the angiotensinogen sequence led to the discovery of potent renin inhibitors with apparent in vitro metabolic stability. Boc-alpha-MePro-Phe-His-Leu psi[CHOHCH2]Val-Ile-Amp dicitrate (Va) is a potent inhibitor o...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00386a016
更新日期:1987-03-01 00:00:00
abstract::In pursuit of truncated glucagon analogues that can interact with the glucagon receptor with substantial binding affinity, 23 truncated glucagon analogues have been designed and synthesized. These truncated analogues consist of several fragments of glucagon with 11 or 12 amino acid residues (1-4), conformationally con...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm000453e
更新日期:2001-04-26 00:00:00
abstract::A broad screening program previously identified phenprocoumon (1) as a small molecule template for inhibition of HIV protease. Subsequent modification of this lead through iterative cycles of structure-based design led to the activity enhancements of pyrone and dihydropyrone ring systems (II and V) and amide-based sub...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9802158
更新日期:1998-08-27 00:00:00
abstract::High-throughput file screening against inhibition of human lung PDE4 led to the discovery of 3-ethyl-1-(4-fluorophenyl)-6-phenyl-7-oxo-4, 5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine (11) as a novel PDE4 inhibitor. Subsequent SAR development, using an eosinophil PDE assay, led to analogues up to 50-fold more potent tha...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9800090
更新日期:1998-06-18 00:00:00
abstract::Despite a myriad of available pharmacotherapies for the treatment of type 2 diabetes (T2D), challenges still exist in achieving glycemic control. Several novel glucose-lowering strategies are currently under clinical investigation, highlighting the need for more robust treatments. Previously, we have shown that suppre...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.0c01450
更新日期:2021-01-28 00:00:00
abstract::A series of novel 3-arylethynyltriazolyl ribonucleosides were synthesized and assessed for their anticancer activity on the drug-resistant pancreatic cancer cell line MiaPaCa-2. Among them, one compound exhibited potent apoptosis-inducing properties and anticancer activity against the pancreatic cancer model MiaPaCa-2...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm900960v
更新日期:2009-10-08 00:00:00
abstract::Production of the Gag-Pol polyprotein in human immunodeficiency virus (HIV) requires a -1 ribosomal frameshift, which is directed by a highly conserved RNA stem-loop. Building on our discovery of a set of disulfide-containing peptides that bind this RNA, we describe medicinal chemistry efforts designed to begin to und...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm100231t
更新日期:2010-08-26 00:00:00
abstract::High throughput screening and subsequent optimization led to the discovery of novel quaternary ammonium salts as highly potent muscarinic acetylcholine receptor antagonists with excellent selectivity. Compounds 8a, 13a, and 13b showed excellent inhibitory activity and long duration of action in bronchoconstriction in ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm800634k
更新日期:2008-08-28 00:00:00
abstract::Although recognized in small molecules for quite some time, the implications of halogen bonding in biomolecular systems are only now coming to light. In this study, several systems of proteins in complex with halogenated ligands have been investigated by using a two-layer QM/MM ONIOM methodology. In all cases, the hal...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9000133
更新日期:2009-05-14 00:00:00
abstract::1-[2-(Diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles (DAMNIs) is a novel family of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) active at submicromolar concentration. Replacement of one phenyl ring of 1-[2-(diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole (4) with heterocyclic rings, such as 2-thien...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm050273a
更新日期:2005-06-30 00:00:00
abstract::The synthesis and biological evaluation of novel prodrugs for use in the antibody directed enzyme prodrug therapy (ADEPT) of cancer based on the cytotoxic antibiotic duocarmycin SA (1) are described. In this approach, we investigated the influence of the sugar moiety of the glycosidic prodrug on the QIC(50) values as ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm8009102
更新日期:2009-01-22 00:00:00
abstract::Cholecystokinin (CCK) has been identified as a pronociceptive endogenous peptide which also possesses antiopioid actions. CCK may be upregulated in conditions of chronic pain or during sustained morphine administration resulting in attenuation of opioid-mediated pain relief. These complex interactions between opioids ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm050921q
更新日期:2006-05-18 00:00:00
abstract::A structure-based virtual screening (SBVS) was conducted on a ligand-supported homology model of the human histamine H4 receptor (hH4R). More than 8.7 million 3D structures derived from different vendor databases were investigated by docking to the hH4R binding site using FlexX. A total of 255 selected compounds were ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm7014777
更新日期:2008-06-12 00:00:00
abstract::Desformylflustrabromine (dFBr; 1), perhaps the first selective positive allosteric modulator of α4β2 neuronal nicotinic acetylcholine (nACh) receptors, was deconstructed to determine which structural features contribute to its actions on receptors expressed in Xenopus ooycytes using two-electrode voltage clamp techn...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm200834x
更新日期:2011-10-27 00:00:00
abstract::A series of methylated analogues of 6-hydroxydopamine (6-OHDA) has been synthesized and evaluated as irreversible inhibitors of catechol O-methyltransferase (COMT). These analogues have been prepared in an effort to elucidate the mechanism involved in the inactivation of this enzyme by 6-OHDA. The analogues prepared h...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00232a007
更新日期:1976-10-01 00:00:00
abstract::The melanocortin-3 (MC3) and melanocortin-4 (MC4) receptors regulate energy homeostasis, food intake, and associated physiological conditions. The melanocortin-4 receptor (MC4R) has been studied extensively. Less is known about specific physiological roles of the melanocortin-3 receptor (MC3R). A major obstacle to thi...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm301253y
更新日期:2013-04-11 00:00:00
abstract::Privileged structures are ligand substructures that are widely used to generate high-affinity ligands for more than one type of receptor. To explain this, we surmised that there must be some common feature in the target proteins. For a set of class A GPCRs, we found a good correlation between conservation patterns of ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm0309452
更新日期:2004-02-12 00:00:00
abstract::A comprehensive herbal medicine information system for cancer (CHMIS-C) has been developed. The current version of the database integrates information on more than 200 anticancer herbal recipes that have been used for the treatment of different types of cancer in clinic, 900 individual ingredients, and 8500 small orga...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm049838d
更新日期:2005-03-10 00:00:00
abstract::The serotonin transporter (SERT) is the primary target for antidepressant drugs. The existence of a high affinity primary orthosteric binding site (S1) and a low affinity secondary site (S2) has been described, and their relation to antidepressant pharmacology has been debated. Herein, structural modifications to the ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm4014136
更新日期:2013-12-12 00:00:00
abstract::Identifying local similarities in binding sites from distant proteins is a major hurdle to rational drug design. We herewith present a novel method, borrowed from computer vision, adapted to mine fragment subpockets and compare them to whole ligand-binding sites. Pockets are represented by pharmacophore-annotated poin...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.0c00422
更新日期:2020-07-09 00:00:00
abstract::The active metabolite (2) of the novel immunosuppressive agent leflunomide (1) has been shown to inhibit the enzyme dihydroorotate dehydrogenase (DHODH). This enzyme catalyzes the fourth step in de novo pyrimidine biosynthesis. A series of analogues of the active metabolite 2 have been synthesized. Their in vivo biolo...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9604437
更新日期:1996-11-08 00:00:00
abstract::Class IIb bacteriocins are ribosomally synthesized antimicrobial peptides comprising two different peptides synergistically acting in equal amounts for optimal potency. In this study, we demonstrate for the first time potent (nanomolar) antimicrobial activity of a representative class IIb bacteriocin, plantaricin S (P...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm101540e
更新日期:2011-04-14 00:00:00